Ben Tre Pharmaceutical Joint Stock Company Sustainability Profile
Ben Tre Pharmaceutical Joint Stock Company, commonly known as Bepharco, is a prominent player in the pharmaceutical industry, headquartered in Ben Tre, Vietnam. Established in 1977, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, catering to both domestic and international markets. With a focus on prescription medications, over-the-counter drugs, and herbal products, Bepharco stands out for its commitment to innovation and quality assurance. The company has achieved notable milestones, including certifications from various health authorities, which underscore its reputation for excellence. As a leader in the Vietnamese pharmaceutical sector, Bepharco continues to expand its operational reach, contributing to the health and well-being of communities while maintaining a strong market position through its diverse product offerings and dedication to research and development.
DitchCarbon Score
How does Ben Tre Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ben Tre Pharmaceutical Joint Stock Company's score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ben Tre Pharmaceutical Joint Stock Company's reported carbon emissions
Ben Tre Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, it is unclear what specific initiatives or commitments the company has made towards reducing its carbon footprint or addressing climate change. In the absence of emissions data and reduction strategies, it is essential for Ben Tre Pharmaceutical to consider establishing measurable climate commitments and targets to align with industry standards and contribute to global sustainability efforts.
How Carbon Intensive is Ben Tre Pharmaceutical Joint Stock Company's Industry?
How Carbon Intensive is Ben Tre Pharmaceutical Joint Stock Company's Location?
Ben Tre Pharmaceutical Joint Stock Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ben Tre Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
